There is more hope than ever surrounding the diagnosis and treatment of dementia. Take care of your brain health and talk to ...

We all know about Alzheimer’s Disease, in fact, many of us know someone who has been impacted by it. But there is another ...

An FDA-approved synthetic THC significantly reduces agitation in Alzheimer's patients, improving treatment outcomes and ...

AG03, developed by researchers at the University of Southampton, targets two critical regions of the tau protein linked to ...

AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.

Nearly seven million Americans are living with Alzheimer’s disease – a leading cause of death in the United States.

While Alzheimer’s can’t be reversed, Leqembi has proven that it can slow down the progression of the disease.

Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer's ...

Summary: A new study finds that brain shrinkage in Alzheimer’s patients does not follow a uniform pattern. Researchers ...

Researchers suggest that the way Alzheimer's reshapes our brains is as unique as our fingerprints, challenging long-held ...

An FDA-approved synthetic version of THC (the main ingredient in cannabis) reduces agitation in patients with Alzheimer's ...